Status:
UNKNOWN
EUS-FNB With MOSE vs EUS-FNA With ROSE
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Pancreatic Neoplasms
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is an indispensable tool for tissue acquisition for pancreatic lesions. However, FNA alone has several limitations including inadequate ac...
Detailed Description
The purpose of this study is to compare the diagnostic yield of EUS-FNB with MOSE vs EUS-FNA with ROSE.
Eligibility Criteria
Inclusion
- Aged between 18 and 80 years
- Referred for EUS-guided tissue acquisition of solid pancreatic lesions greater than 1cm in the largest diameter
Exclusion
- Coagulopathy
- Altered anatomy
- Contraindications for conscious sedation
- Pregnancy
- Those who cannot provide informed consent
Key Trial Info
Start Date :
June 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT03766659
Start Date
June 19 2019
End Date
September 1 2024
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery; The Chinese University of Hong Kong
Hong Kong, Hong Kong